The Heads of HTA Agencies Group (HAG) welcomes the adoption of the first implementing regulation ((EU) 2024/1381) by the European Commission pursuant to the HTA Regulation ((EU) 2021/2282).
📌 This implementing regulation is a major milestone in the implementation of the HTA Regulation outlining the procedural rules and templates for the conduct of Joint Clinical Assessments (JCA) for medicinal products.
📌 The HAG is unified in its support for the HTA Regulation and will remain active in promoting important discussions for the remaining implementing regulations to be passed before joint production begins in 2025.
👉 Implementing regulation ((EU) 2024/1381): https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L_202401381